Peginterferon beta-1b biosimilar - PfenexAlternative Names: PF-726
Latest Information Update: 16 Jul 2016
At a glance
- Originator Pfenex - Agila Biotech (JV)
- Developer Pfenex
- Class Antivirals; Interferons; Polyethylene glycols
- Mechanism of Action Interferon beta stimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- No development reported Multiple sclerosis